Intense and recurrent déjà vu experiences related to amantadine and phenylpropanolamine in a healthy male

Journal of Clinical Neuroscience

Volumn 8, Issue 5, 2001, Pages 460-462

  Taiminen, Tero ^a   Jääskeläinen, Satu K ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Amantadine; D j vu; Dopamine; Paramnesia; Phenylpropanolamine

Indexed keywords

AMANTADINE; PHENYLPROPANOLAMINE;

ADULT; ARTICLE; DEJA VU; DOPAMINERGIC SYSTEM; HIPPOCAMPUS; HUMAN; MALE; NORMAL HUMAN; PHYSICIAN; PRIORITY JOURNAL; PSYCHOSIS; RECURRENT DISEASE; SYMPTOM; TEMPORAL LOBE EPILEPSY;

EID: 0034855792     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1054/jocn.2000.0810     Document Type: Article

References (17)

1. Possible use of amantadine in depression
2. Clinical use of amantadine in brain injury rehabilitation
3. Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients
4. Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine
5. Mental side effects of amantadine therapy: Its spectrum and characteristics in a normal population
6. Phenylpropanolamine-induced psychosis: Potential predisposing factors
7. Psychic seizures
8. Episodic psychic symptoms in the general population
9. Déjà vu as related to diagnostic categories in psychiatric and neurosurgical patients
10. Déjà vu experiences and reduplicative paramnesia
11. Development, reliability, and validity of a dissociation scale
12. Psychotic episode related to phenylpropanolamine and amantadine in a healthy female
13. Prediction of detached personality in healthy subjects by low dopamine transporter binding
14. 2 systems and spatial working memory in rats